Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Chimeric Therapeutics Ltd. ( (AU:CHM) ) has provided an announcement.
Chimeric Therapeutics has requested and been granted a trading halt on its securities by the ASX as it prepares to announce details of a material capital raising. The halt will remain in place until the anticipated announcement is released or until the start of normal trading on 23 December 2025, signalling that the company is undertaking a significant funding initiative that could influence its capital structure and near-term strategic activities.
More about Chimeric Therapeutics Ltd.
Chimeric Therapeutics Limited (ASX: CHM) is an Australian-listed biotechnology company operating in the therapeutics sector, focused on developing medical treatments, with its securities traded on the Australian Securities Exchange.
Technical Sentiment Signal: Sell
Current Market Cap: A$12.75M
For a thorough assessment of CHM stock, go to TipRanks’ Stock Analysis page.